Literature DB >> 15838864

Cytokine and growth factor receptors in the nucleus: what's up with that?

John J Krolewski1.   

Abstract

Signaling via cell surface receptors that are anchored by a single transmembrane domain is a well-established paradigm. Ligand binding to the extracellular domain of the receptor facilitates receptor dimerization, which juxtaposes the intracellular domains, typically activating intrinsic or associated kinases. Two large families of tyrosine kinase activating receptors have been particularly well characterized: the receptor-type protein tyrosine kinases and the receptors for the alpha-helical cytokines, which activate non-covalently bound JAK family tyrosine kinases. Despite the well-established function of these receptors at the cell surface, both intact and cleaved receptors belonging to these families have been repeatedly detected in the nucleus. Furthermore, there is evidence that some of these receptors or receptor fragments function directly in modulating gene transcription. In this essay, I examine how close we are to demonstrating that direct translocation of receptors, or receptor fragments, from the cell surface to the nucleus is a physiologically relevant means of intracellular signaling that can supplant or complement canonical signaling cascades. (c) 2005 Wiley-Liss, Inc.

Mesh:

Substances:

Year:  2005        PMID: 15838864     DOI: 10.1002/jcb.20451

Source DB:  PubMed          Journal:  J Cell Biochem        ISSN: 0730-2312            Impact factor:   4.429


  8 in total

1.  Mechanical signals activate vascular endothelial growth factor receptor-2 to upregulate endothelial cell proliferation during inflammation.

Authors:  Jie Liu; Sudha Agarwal
Journal:  J Immunol       Date:  2010-06-14       Impact factor: 5.422

2.  HER family receptor abnormalities in lung cancer brain metastases and corresponding primary tumors.

Authors:  Menghong Sun; Carmen Behrens; Lei Feng; Natalie Ozburn; Ximing Tang; Guosheng Yin; Ritsuko Komaki; Marileila Varella-Garcia; Waun Ki Hong; Kenneth D Aldape; Ignacio I Wistuba
Journal:  Clin Cancer Res       Date:  2009-07-21       Impact factor: 12.531

3.  The extracellular domain of the growth hormone receptor interacts with coactivator activator to promote cell proliferation.

Authors:  Becky L Conway-Campbell; Andrew J Brooks; Philip J Robinson; Michela Perani; Michael J Waters
Journal:  Mol Endocrinol       Date:  2008-07-17

Review 4.  The epidermal growth factor receptor family: biology driving targeted therapeutics.

Authors:  M J Wieduwilt; M M Moasser
Journal:  Cell Mol Life Sci       Date:  2008-05       Impact factor: 9.261

5.  Nuclear targeting of IGF-1 receptor in orbital fibroblasts from Graves' disease: apparent role of ADAM17.

Authors:  Neil Hoa; Shanli Tsui; Nikoo F Afifiyan; Amiya Sinha Hikim; Bin Li; Raymond S Douglas; Terry J Smith
Journal:  PLoS One       Date:  2012-04-10       Impact factor: 3.240

6.  Nuclear epidermal growth factor receptor (EGFR) interacts with signal transducer and activator of transcription 5 (STAT5) in activating Aurora-A gene expression.

Authors:  Liang-Yi Hung; Joseph T Tseng; Yi-Chao Lee; Weiya Xia; Ying-Nai Wang; Min-Li Wu; Yu-Hsuan Chuang; Chein-Hsien Lai; Wen-Chang Chang
Journal:  Nucleic Acids Res       Date:  2008-06-27       Impact factor: 16.971

Review 7.  Nuclear EGFR signalling network in cancers: linking EGFR pathway to cell cycle progression, nitric oxide pathway and patient survival.

Authors:  H-W Lo; M-C Hung
Journal:  Br J Cancer       Date:  2006-01-30       Impact factor: 7.640

8.  Physical and functional interactome atlas of human receptor tyrosine kinases.

Authors:  Xiaonan Liu; Tiina Öhman; Kari Salokas; Iftekhar Chowdhury; Lisa Gawriyski; Salla Keskitalo; Markku Varjosalo
Journal:  EMBO Rep       Date:  2022-04-05       Impact factor: 9.071

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.